DIA
Drug Information Association Logo
« Back to Listing

Pharmaceuticals and Medical Devices Agency (PMDA) Town Hall

Track:
Global Regulatory

Day & Time:
June 17, 8:00AM - 9:30AM (Pacific Standard Time)

Session Number:
224

Room Number:
6F

Level:
Intermediate

Type:
Forum

Title:
Pharmaceuticals and Medical Devices Agency (PMDA) Town Hall

Chair(s):
Nobumasa Nakashima, PhD
International Planning Director (Pharmaceutical Affairs), Ministers Affairs
Ministry of Health, Labour and Welfare (MHLW) , Japan

Description:
Representatives from the Pharmaceuticals and Medical Devices Agency (PMDA) will explain its current services and the Japanese drug regulation, and answer your questions on PMDA’s future initiatives/challenges for faster review and better life cycle management of drugs.

Please come prepared with your questions for the PMDA Town Hall panel. You may submit questions and topics of interest in advance to annualmeetingprogram@diahome.org, and include “PMDA Town Hall” in the subject line.

Learning Objective(s):
Discuss the current situation of PMDA and Japanese regulation; Communicate with PMDA senior officials on Japanese drug regulatory issues.

Presentation(s) & Speaker(s):
Future Plan of PMDA for the Next Five Years
Tatsuya Kondo, MD, PhD
Chief Executive
Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Introduction of the Third 5-Year Mid-Term Plan of PMDA
Masaru Hiraiwa
Director, Office of Planning and Coordination
Pharmaceuticals and Medical Devices Agency (PMDA), Japan

PMDA's Efforts in the Medical Area
Tetsuo Nagano, PhD
Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Safety Measures: The Risk Management Plan in Japan
Hiroshi Yamamoto, MS
Chief Safety Officer
Pharmaceuticals and Medical Devices Agency (PMDA), Japan